Real World Study of a Adalimumab Biosimilar (Geleli) in Rheumatoid Arthritis

Condition:   Rheumatoid Arthritis Intervention:   Drug: Geleli Sponsor:   Peking University People's Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials